Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study
Open Access
- 1 September 2016
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 10 (6), 525-531
- https://doi.org/10.1111/irv.12410
Abstract
Background: During the pandemic outbreak of the 2009 swine influenza (A(H1N1) pdm09), 32 fatal cases occurred in Norway and 19 of these were included in this study. Objectives: We characterised pulmonary changes in these fatal Norwegian cases. Patients and Methods: Upon hospitalisation, detailed clinical information and specimens from the upper and lower respiratory pathways were collected. At post-mortem, lung tissue was collected, formalin-fixed and paraffin-embedded. Immunohistochemical and light microscopic examination was performed to visualise the local expression of the A(H1N1) pdm09 virus. Reverse transcription-polymerase chain reaction (RT-PCR) and pyrosequencing of the non-fixed specimens allowed the identification of mutations in the influenza virus surface glycoprotein (haemagglutinin gene) particularly at position 222. Results and Conclusions: The overall course of illness lasted from 2 to 40 days (median 9 days). Diffused alveolar damage (DAD) was evident in 11 cases, 4 of which had no apparent underlying illness. Obesity was prominent in 12 cases, where three individuals were classified as otherwise healthy. The HA D222G mutation was detected in six cases, 3 of which had no underlying illness. Immunohistochemistry showed the A(H1N1) pdm09 virus to be prominent at the site of inflammation both in close proximity to and inside alveolar structures in the lung tissue. In addition to a possible role for the HA D222G mutation, our findings indicate that host factors and underlying conditions in the infected individuals are fundamental for disease outcome in many cases. This study increases our understanding of determinants for the clinical outcome of pandemic influenza, which could guide future treatment.Funding Information
- Universitetet i Bergen
- Helse- og Omsorgsdepartementet
- Norges Forskningsråd (220670/H10)
- European Union Agency for Network and Information Security (Univax 601738, EU IMI, FLUCOP 115672)
This publication has 40 references indexed in Scilit:
- A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in MexicoVirology Journal, 2013
- Influenza virus vaccines: lessons from the 2009 H1N1 pandemicCurrent Opinion in Virology, 2011
- Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled AnalysisPLoS Medicine, 2011
- Hospitalised patients with suspected 2009 H1N1 Influenza A in a hospital in Norway, July - December 2009BMC Infectious Diseases, 2011
- Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, ChinaBMC Infectious Diseases, 2010
- Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) DiseasePLOS ONE, 2010
- 2009 H1N1 InfluenzaMayo Clinic Proceedings, 2010
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusThe New England Journal of Medicine, 2009
- Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with LysosomesCell Host & Microbe, 2009
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoThe New England Journal of Medicine, 2009